Literature DB >> 15325924

Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.

Nathan D Wong1, Miwa Kawakubo, Laurie LaBree, Stanley P Azen, Min Xiang, Robert Detrano.   

Abstract

Tracking of coronary artery calcium (CAC) has been suggested for monitoring the effects of lipid control, but it is not known whether lipid control decreases progression of CAC. Seven hundred sixty-one subjects (mean age 64.5 +/- 7.3 years; 91% men; 69% positive for CAC) in an ongoing cohort study underwent baseline and follow-up (after 7.0 +/- 0.5 years) computed tomography for CAC. Subjects were stratified into low-risk (<2 risk factors), intermediate-risk (> or =2 risk factors but <20% risk of coronary heart disease over 10 years), or high-risk (> or =2 risk factors and >20% risk of coronary heart disease in 10 years or diabetes) groups. Lipid control was defined according to criteria of the National Cholesterol Education Program. Two-way analysis of covariance was used to examine the relation of low-density lipoprotein (LDL) cholesterol and risk group to change in CAC volume score. Control of levels of high-density lipoprotein (HDL) cholesterol and triglycerides was also examined in relation to progression of CAC. After adjustment for other risk factors and baseline CAC volume, CAC progression was similar between those with adequate and those with inadequate control of LDL cholesterol (p = 0.68) and across categories of optimal, intermediate, and higher risk LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/L [60 mg/dl]) were associated with less progression of CAC volume (151 vs 203 mm(3) in those with HDL cholesterol <1.0 mmol/L [40 mg/dl], p = 0.03). There was no relation between triglycerides and CAC progression (p = 0.54). Our findings do not support the use of CAC assessment for monitoring the control of LDL cholesterol, but greater progression of CAC may occur in those in whom HDL cholesterol is not controlled.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325924     DOI: 10.1016/j.amjcard.2004.05.003

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Coronary artery calcium scoring and its impact on the clinical practice in the era of multidetector CT.

Authors:  Jongmin Lee
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-20       Impact factor: 2.357

2.  The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study.

Authors:  Lewis H Kuller; Andrea M Kriska; Laura S Kinzel; Laurey R Simkin-Silverman; Kim Sutton-Tyrrell; B Delia Johnson; Molly B Conroy
Journal:  Contemp Clin Trials       Date:  2006-10-14       Impact factor: 2.226

3.  Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Authors:  Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

4.  Current and future status on cardiac computed tomography imaging for diagnosis and risk stratification.

Authors:  Stephan Achenbach
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management.

Authors:  Victor K Goh; Chu-Pak Lau; Stefan Mohlenkamp; John A Rumberger; Stephan Achenbach; Matthew J Budoff
Journal:  Cardiovasc Ultrasound       Date:  2010-03-12       Impact factor: 2.062

6.  Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study.

Authors:  Sang-Eun Lee; Ji Min Sung; Daniele Andreini; Matthew J Budoff; Filippo Cademartiri; Kavitha Chinnaiyan; Jung Hyun Choi; Eun Ju Chun; Edoardo Conte; Ilan Gottlieb; Martin Hadamitzky; Yong Jin Kim; Amit Kumar; Byoung Kwon Lee; Jonathon A Leipsic; Erica Maffei; Hugo Marques; Gianluca Pontone; Gilbert Raff; Sanghoon Shin; Peter H Stone; Habib Samady; Renu Virmani; Jagat Narula; Daniel S Berman; Leslee J Shaw; Jeroen J Bax; Fay Y Lin; James K Min; Hyuk-Jae Chang
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-11-01       Impact factor: 6.875

7.  Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study.

Authors:  Nathan D Wong; Jennifer C Nelson; Tanya Granston; Alain G Bertoni; Roger S Blumenthal; J Jeffrey Carr; Alan Guerci; David R Jacobs; Richard Kronmal; Kiang Liu; Mohammed Saad; Elizabeth Selvin; Russell Tracy; Robert Detrano
Journal:  JACC Cardiovasc Imaging       Date:  2012-04

8.  Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Matthew J Budoff; Rebekah Young; Victor A Lopez; Richard A Kronmal; Khurram Nasir; Roger S Blumenthal; Robert C Detrano; Diane E Bild; Alan D Guerci; Kiang Liu; Steven Shea; Moyses Szklo; Wendy Post; Joao Lima; Alain Bertoni; Nathan D Wong
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

Review 9.  Arterial calcifications.

Authors:  Roger J M W Rennenberg; Leon J Schurgers; Abraham A Kroon; Coen D A Stehouwer
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

10.  Risk Factors for Long-Term Coronary Artery Calcium Progression in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Amanda J Gassett; Lianne Sheppard; Robyn L McClelland; Casey Olives; Richard Kronmal; Michael J Blaha; Matthew Budoff; Joel D Kaufman
Journal:  J Am Heart Assoc       Date:  2015-08-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.